Senate bill · 119th Congress · Latest step: Introduced
Pharmaceutical Investment Oversight and Accountability Act
Official title: A bill to require the Federal Trade Commission to submit a report on foreign investment in the pharmaceutical industry of the United States, and for other purposes.
Sponsor: Sen. Elizabeth Warren D-MAWhere it went
- IntroducedJul 15, 2026
- Committee action—
- Passed Senate—
- Passed House—
- To the President—
- Became law—
Latest action: Jul 15, 2026 — Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Vote results
No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).
Cosponsors
2 cosponsors — 1 Republican, 1 Democrat
1 of 2 cosponsors (50%) are from the other party.
More from the sponsor
Other 119th Congress bills sponsored by Sen. Elizabeth Warren.
- S.Res. 422 (119th) A resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of September 2025…
- S.Res. 937 (119th) A resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of September 2026…
- S. 2197 (119th) Refund Equality Act of 2025
- S.Res. 732 (119th) A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving…
- S. 3948 (119th) Direct File Act of 2026
- S. 2006 (119th) Fit to Serve Act
Related bills
- S. 1367 (117th) United States Pharmaceutical Supply Chain Review ActCross-Congress related bill
Relationships as recorded by Congress.gov.
Sponsor’s state and district
Data as of Sep 25, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.